Latest news and articles about Hui Min Bao
Total: 1 articles found
The NHSA has reported significant expansion in the availability of high-cost innovative drugs through commercial insurance channels, doubling the number of participating medical institutions in early 2026. This move is part of a broader strategy to preserve the state's basic insurance fund while creating a viable market for high-end pharmaceutical innovation through commercial partnerships.
